|
May
is Brain Tumor Awareness Month

On May 21, 2008, the
United States House of Representatives approved H. Res. 1124, a
resolution sponsored by Representative Janice Schakowsky (D-IL), and
by this action established May as National Brain Tumor Awareness
Month.
Brain tumors are the
second most common cancer of childhood (after leukemia) and comprise
approximately 25% of all pediatric cancers. Over 3,400 children are
diagnosed in the U.S. each year; of that,
about 2,600 will be under the age of 15. Brain tumors are the
leading cause of solid tumor cancer death in children. The types of
brain tumors found in children are different from those in adults.
Further complicating treatment is the fact that children's
developing brains are more susceptible to damage from toxic
treatments. Although more than 70% of children now survive their
tumors, they are often left with long-term side-effects,
including:
-
Learning problems due
to cognitive, neurological, and psychological changes.
-
Vision and/or hearing
impairments that can contribute to problems in school.
-
Increased risk for
second cancers due to the late-effects of
treatment.
|
The treatment of brain
tumors is a multidisciplinary practice, involving an extensive team
of dedicated specialists. For the future, research is essential and
critical to sustained progress and effective treatments. Promising
areas of research include molecular genetics of CNS tumors,
identification of cellular mutations which can be targets of
treatment, and tumor vaccine development. The existing and future
projects are designed to lead to new treatments, new diagnostic
methods, and strategies to prevent childhood cancer. Our research
includes both laboratory-centered basic and translational ventures
and clinical (or patient) based investigations in a wide spectrum of
projects.
With the leadership gift
from the Alfano Family Foundation, an outstanding program in
pediatric neuro-oncology has evolved within the Division of
Pediatric Oncology with ongoing and remarkable progress. The team,
led by James Garvin, MD PhD, includes Manuela Orjuela, MD,
Neuro-Oncologist, Eileen Stark, RN, MS, CPNP, Nurse Practitioner,
Betty Cruz, Coordinator, and Candida Batista, MSW, Social Worker.
With participating physicians in specialties such as molecular
epidemiology, pediatric neurosurgery, radiation oncology, pediatric
neurology, and neuropathology, the program’s activities, teaching
and outreach are extensive.

|